4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-036652
Options or other derivatives
- Director acquired 8,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Powell Andrew Kenneth William Director | 2018-06-07 | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | D | ||
Loading xslF345X03/doc4.xml…